← Back
Data updated: Jul 17, 2026
APRECIA PHARMS
Pharma Pharmaceuticals
APRECIA PHARMS is a pharmaceutical company with 1 FDA-approved products.
2015
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
APRECIA PHARMS's Key Drugs
APRECIA PHARMS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
APRECIA PHARMS's Recent FDA Approvals
New NDA/BLA approvals for APRECIA PHARMS over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
APRECIA PHARMS's Therapeutic Areas
Disease areas where APRECIA PHARMS has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
APRECIA PHARMS Pipeline Snapshot
Active clinical trials for APRECIA PHARMS across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (1)
Company Info
- First Approval
- 2015-07-31
- Latest
- 2025-06-27
- Applications
- 1